Acquisitions, Sale of Hospira Infusion Systems Net Assets, Collaborative Arrangement and Equity-Method Investments - Anacor Pharmaceuticals, Inc. (Details) - USD ($) $ / shares in Units, $ in Millions			9 Months Ended
		Jun. 24, 2016	Oct. 01, 2017	Oct. 02, 2016	Dec. 31, 2016
Business Acquisition [Line Items]
Cash payments for acquisition, net of cash acquired	[1]		$ 1,000	$ 17,679
Goodwill	[2]		$ 56,078		$ 54,449
Anacor [Member]
Business Acquisition [Line Items]
Business acquisition, per share in cash (in dollars per share)		$ 99.25
Payments for acquisitions, cash portion		$ 4,900
Cash payments for acquisition, net of cash acquired		4,500
Debt assumed		698
IPR&D		4,900
Goodwill		646
Deferred tax liabilities		346
Anacor [Member] | In Process Research and Development [Member]
Business Acquisition [Line Items]
Identifiable intangible assets		$ 4,800

[1] Amounts may not add due to rounding.

[2] Amounts may not add due to rounding.